Is Breast Cancer Research Foundation Inc Legit?

The Breast Cancer Research Foundation Inc. demonstrates strong financial health and a consistent commitment to its program services. Over the past several years, the organization has shown significant revenue growth, with the latest reported revenue at $195,619,100, a substantial increase from $94,756,928 in 2023 and $84,528,969 in 2022. This growth has allowed for increased program spending, which is a positive indicator of impact. The organization consistently allocates a high percentage of its expenses directly to programs, indicating efficient use of donor funds towards its mission of breast cancer research. While specific detailed breakdowns for administrative and fundraising costs are not provided in the summary data, the overall financial picture suggests a well-managed organization. The consistent growth in assets, reaching $199,068,927, alongside increasing revenue, points to a stable and expanding financial base. The absence of reported officer compensation in the provided filings is a notable aspect regarding executive remuneration, suggesting that top leadership may be compensated through other means or that the organization prioritizes directing funds to its mission. Overall, the Breast Cancer Research Foundation Inc. appears to be a financially robust and program-focused charity. Its ability to consistently generate significant revenue and direct a large portion of it towards its core mission, as evidenced by the high program spending ratio, reflects positively on its operational efficiency and dedication to its cause. The growth trajectory in both revenue and assets further solidifies its position as a well-resourced entity in the nonprofit sector.